| Stage | ENS | % of rev | ULBI | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $936M | 100.00% | $48M | 100.00% | ENS ×19.52 |
| Gross profit | $313M | 33.49% | $14M | 28.92% | ENS +4.6pp |
| Operating income | $151M | 16.18% | $3M | 7.17% | ENS +9.0pp |
| Pre-tax income | $135M | 14.43% | $3M | 6.23% | ENS +8.2pp |
| Net income | $116M | 12.45% | $3M | 5.25% | ENS +7.2pp |
| Stage | ENS | ULBI | Gap · A − B |
|---|---|---|---|
| Revenue | $936M100.00% | $48M100.00% | ENS ×19.52 |
| Gross profit | 33.49%$313M | 28.92%$14M | ENS +4.6pp |
| Operating income | 16.18%$151M | 7.17%$3M | ENS +9.0pp |
| Pre-tax income | 14.43%$135M | 6.23%$3M | ENS +8.2pp |
| Net income |
| 12.45%$116M |
| 5.25%$3M |
| ENS +7.2pp |
No shared counterparties.